Internal Medicine, Nephrology · Memphis, TN
NPI
1720057714
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
6490 Mount Moriah Road Ext, Suite 200
Memphis, TN, 38115
Phone (901) 565-0244
Groups this clinician bills Medicare through
Medicare paid, 2024
$433K
6,981 services
Medicare patients, 2024
1,058
Average age 74
Drug cost, 2024
$800K
2,092 prescriptions
Company payments, 2025
$1,402
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick S Kulubya was code 99458 (e&m - miscellaneous), 1,340 times for 105 patients. In total Patrick S Kulubya billed 6,981 services in 30 codes, and Medicare paid $433K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99458 E&M - Miscellaneous | Office | 1,340 | 105 | $30.93 | $41K |
| 99232 Hospital E&M - Subsequent | Facility | 1,110 | 460 | $61.49 | $68K |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 892 | 111 | $37.08 | $33K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 655 | 114 | $48.63 | $32K |
| 99457 E&M - Miscellaneous | Office | 623 | 109 | $38.19 | $24K |
| 99454 E&M - Miscellaneous | Office | 538 | 87 | $35.46 | $19K |
| 99214 Office E&M - Established | Office | 480 | 353 | $86.31 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 268 | 222 | $12.92 | $3,463 |
| 90966 ESRD Related Services (not dialysis) | Office | 226 | 44 | $218.42 | $49K |
| 99223 Hospital E&M - Initial | Facility | 164 | 156 | $133.81 | $22K |
| 90935 Hemodialysis | Facility | 149 | 90 | $55.28 | $8,237 |
| 90960 ESRD Related Services (not dialysis) | Office | 142 | 31 | $264.62 | $38K |
| 90961 ESRD Related Services (not dialysis) | Office | 141 | 42 | $220.48 | $31K |
| 99233 Hospital E&M - Subsequent | Facility | 74 | 52 | $93.33 | $6,906 |
| 99222 Hospital E&M - Initial | Facility | 64 | 56 | $102.47 | $6,558 |
By year: 2022 $292K for 2,991 services; 2023 $280K for 2,663 services; 2024 $433K for 6,981 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patrick S Kulubya prescribed most often to Medicare patients was Velphoro (Sucroferric Oxyhydroxide), with 232 prescriptions and refills. In total Patrick S Kulubya wrote 2,092 Medicare prescriptions that cost $800K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Velphoro Sucroferric Oxyhydroxide | 232 | 252 | 51 | $576K |
| Sevelamer Carbonate Generic | 185 | 318 | 57 | $45K |
| Amlodipine Besylate Generic | 144 | 296 | 46 | $684 |
| Hydralazine Hcl Generic | 124 | 224 | 35 | $1,421 |
| Losartan Potassium Generic | 90 | 186 | 32 | $641 |
| Furosemide Generic | 82 | 145 | 31 | $390 |
| Potassium Chloride Generic | 80 | 146 | 30 | $1,045 |
| Carvedilol Generic | 79 | 173 | 26 | $588 |
| Veltassa Patiromer Calcium Sorbitex | 64 | 78 | 21 | $57K |
| Clonidine Hcl Generic | 63 | 87 | 20 | $390 |
| Farxiga Dapagliflozin Propanediol | 56 | 80 | 13 | $44K |
| Olmesartan Medoxomil Generic | 51 | 89 | 14 | $423 |
| Atorvastatin Calcium Generic | 48 | 102 | 16 | $314 |
| Cinacalcet Hcl Generic | 44 | 48 | Under 11 | $3,066 |
| Lisinopril Generic | 37 | 85 | 13 | $151 |
Brand drugs: - claims; generic drugs: 1,650 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick S Kulubya $1,402 ($1,402 in general payments such as food, travel and fees) from 15 companies. The largest payer was Lilly USA, LLC with $215.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 8 | $215 |
| Ardelyx, Inc. ARDX | 8 | $200 |
| Calliditas Therapeutics US Inc. | 8 | $160 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $159 |
| Vifor Pharma, Inc. | 7 | $142 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $116 |
| Travere Therapeutics, Inc. TVTX | 6 | $101 |
| Mallinckrodt Hospital Products Inc. | 3 | $86.38 |
| Fresenius USA Marketing, Inc. | 4 | $81.18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.